GeneDx Holdings (WGSWW) Depreciation & Amortization (CF) (2020 - 2026)

GeneDx Holdings (WGSWW) has 7 years of Depreciation & Amortization (CF) data on file, last reported at $6.8 million in Q1 2026.

• Depreciation & Amortization (CF) for Q1 2026 came in at $6.8 million, up 19.92% year-over-year; the trailing twelve-month figure through Mar 2026 was $26.4 million (up 17.75% YoY), and the FY2025 annual result was $25.2 million, up 14.9% from the prior year.
• Depreciation & Amortization (CF) declined to $6.8 million in Q1 2026 per WGSWW's latest filing, from $6.9 million in the prior quarter.
• Over five years, Depreciation & Amortization (CF) peaked at $34.0 million in Q4 2022 and troughed at $5.2 million in Q2 2024.
• A 5-year average of $8.6 million and a median of $6.5 million in 2025 frame the typical range for Depreciation & Amortization (CF).
• The sharpest annual moves came in 2022 and 2023: Depreciation & Amortization (CF) jumped 487.4% in 2022, then tumbled 82.1% in 2023.
• A 5-year view of Depreciation & Amortization (CF) shows it stood at $34.0 million in 2022, then plunged by 82.1% to $6.1 million in 2023, then fell by 8.8% to $5.6 million in 2024, then advanced by 23.8% to $6.9 million in 2025, then declined by 1.05% to $6.8 million in 2026.
• Business Quant data shows WGSWW's Depreciation & Amortization (CF) at $6.8 million in Q1 2026, $6.9 million in Q4 2025, and $6.5 million in Q3 2025.